Centanafadine
Centanafadine (INN) (former developmental code name EB-1020) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that began its development with Euthymics Bioscience after they acquired DOV Pharmaceutical. It was developed as a treatment for attention-deficit hyperactivity disorder (ADHD) and inhibits the reuptake of norepinephrine, dopamine, and serotonin with a ratio of 1:6:14, respectively. In 2011, Euthymics Bioscience spun off its development of centanafadine to a new company called Neurovance. In March 2017, Otsuka Pharmaceutical acquired Neurovance and the rights to centanafadine. As of January 2018, Otsuka's pipeline indicates it is in Phase III clinical trials.
Link from a Wikipage to another Wikipage
primaryTopic
Centanafadine
Centanafadine (INN) (former developmental code name EB-1020) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that began its development with Euthymics Bioscience after they acquired DOV Pharmaceutical. It was developed as a treatment for attention-deficit hyperactivity disorder (ADHD) and inhibits the reuptake of norepinephrine, dopamine, and serotonin with a ratio of 1:6:14, respectively. In 2011, Euthymics Bioscience spun off its development of centanafadine to a new company called Neurovance. In March 2017, Otsuka Pharmaceutical acquired Neurovance and the rights to centanafadine. As of January 2018, Otsuka's pipeline indicates it is in Phase III clinical trials.
has abstract
Centanafadine (INN) (former de ...... in Phase III clinical trials.
@en
CAS number
924012-43-1
FDA UNII code
D2A6T4UH9C
KEGG
PubChem
Link from a Wikipage to an external page
Wikipage page ID
48,554,101
page length (characters) of wiki page
Wikipage revision ID
992,037,141
Link from a Wikipage to another Wikipage
CAS number
ChemSpiderID
17,253,639
IUPAC name
KEGG
D10697
@en
legal US
Investigational New Drug
@en
PubChem
16,095,349
SMILES
C1=C[C@@]34C[C@@H]3CNC4
@en
StdInChIKey
HKHCSWPSUSWGLI-CABCVRRESA-N
@en
UNII
D2A6T4UH9C
@en
wikiPageUsesTemplate
subject
hypernym
comment
Centanafadine (INN) (former de ...... in Phase III clinical trials.
@en
label
Centanafadine
@en